Kurtz, K., Ma, E., Chi, Y., Malvar, J., Tan, Y., Schafer, E., Pauly, M., Kaplan, J., Pommert, L., Rossoff, J., Gaynon, P., Hijiya, N., Huynh, V., Rheingold, S., Schore, R., Faulk, K., Heym, K., Place, A., Batra, S., Shaw, P., Cooper, S., Karol, S., Khaw, S. L., August, K., Barredo, J., Agrusa, J., Gossai, N., Sulis, M. L., Colace, S., Chang, B., Dallas, M., Cooper, T., McCleary, K., Hermiston, M., Heneghan, M., Slone, T., Dalla-Pozza, L., Graff, Z., Shin-Kashiyama, E., Wayne, A., Bhojwani, D. (2025). Identifying barriers to clinical trial enrollment for children with relapsed or refractory hematologic malignancies. Blood. https://doi.org/10.1182/blood-2025-4404